Common skin infections in children.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

19 citing papers in PubMed.

1. Ozenoxacin, a New Effective and Safe Topical Treatment for Impetigo in Children and Adolescents.Dermatology (Basel, Switzerland) · 2020
   Trial
2. Efficacy and Safety of Ozenoxacin Cream for Treatment of Adult and Pediatric Patients With Impetigo: A Randomized Clinical Trial.JAMA dermatology · 2018
   Trial
3. Ozenoxacin 1% in Pediatric and Adult Patients with Impetigo: A Meta-Analysis of Randomized Trials.Journal of clinical medicine · 2025
   Review
4. The global, regional, and national patterns of change in the burden of bacterial pyoderma from 1990 to 2019 and the forecast for the next decade.Scientific reports · 2025
   Article
5. Intolerable Burden of Impetigo in Endemic Settings: A Review of the Current State of Play and Future Directions for Alternative Treatments.Antibiotics (Basel, Switzerland) · 2020
   Review
6. Impetigo Animal Models: A Review of Their Feasibility and Clinical Utility for Therapeutic Appraisal of Investigational Drug Candidates.Antibiotics (Basel, Switzerland) · 2020
   Review
7. Safety and efficacy profile of ozenoxacin 1% cream in pediatric patients with impetigo.International journal of women's dermatology · 2020
   Article
8. Prevalence and Associations of General Practice Registrars' Management of Impetigo: A Cross-Sectional Analysis From the Registrar Clinical Encounters in Training (ReCEnT) Study.Dermatology practical & conceptual · 2020
   Article
9. Antibiotic stewardship in skin infections: a cross-sectional analysis of early-career GP's management of impetigo.BMJ open · 2019
   Article
10. Increase of scabies infestations, Norway, 2006 to 2018.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2019
    Article
11. Mutant prevention concentration of ozenoxacin for quinolone-susceptible or -resistant Staphylococcus aureus and Staphylococcus epidermidis.PloS one · 2019
    Article
12. Mie scatter spectra-based device for instant, contact-free, and specific diagnosis of bacterial skin infection.Scientific reports · 2017
    Article
13. Warts of the Fingertips in a Pediatric Patient With Type 1 Diabetes.Clinical diabetes : a publication of the American Diabetes Association · 2017
    Article
14. Skin infections in male pupils of primary schools in Al Ahsa.Journal of family & community medicine · 2013
    Article
15. Reported incidence and treatment of dermatophytosis in children in general practice: a comparison between 1987 and 2001.Mycopathologia · 2007
    Article
16. Scabies: diagnosis and treatment.BMJ (Clinical research ed.) · 2005
    Review
17. More common skin infections in children.BMJ (Clinical research ed.) · 2005
    Review
18. Molluscum contagiosum is not always benign.BMJ (Clinical research ed.) · 2004
    Article
19. Antifungal Activity of N-Arylbenzoquinaldinium Derivatives against a Clinical Strain ofIndian journal of dermatology
    Article

Corrections and comments

• Commented on by
  Molluscum contagiosum is not always benign.2004

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as